🇺🇸 FDA

Company profile · Sponsor

Alfasigma

Alfasigma S.p.A.

EDE7C49 · EMA pharma EU
Pipeline
7
Drugs
0
Patents
0

Quick answer

Alfasigma (EDE7C49) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 7 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker EDE7C49
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (7)

Search pipeline →

  1. GLPG0634, Jyseleca 200 mg film-coated tablets, Jyseleca 100 mg film-coated tablets

    Alfasigma

    Ulcerative colitis

    phase 3 small molecule active

    1 trial

  2. GLPG0634, Jyseleca 200 mg film-coated tablets, Jyseleca 100 mg film-coated tablets

    Alfasigma

    Juvenile idiopathic arthritis

    phase 3 small molecule active

    1 trial

  3. Jyseleca 100 mg film-coated tablets, Jyseleca 200 mg film-coated tablets

    Alfasigma

    Rheumatoid arthritis

    phase 3 small molecule active

    1 trial

  4. Jyseleca 100 mg film-coated tablets, Jyseleca 200 mg film-coated tablets, Composition apart from the active substance otherwise to identical to IMP

    Alfasigma

    Ulcerative Colitis (UC)

    phase 3 small molecule active

    1 trial

  5. Jyseleca 200 mg film-coated tablets, Jyseleca 100 mg film-coated tablets, GLPG0634

    Alfasigma

    Polyarticular-course juvenile idiopathic arthritis

    phase 3 small molecule active

    1 trial

  6. A TWO-PART ABSOLUTE BIOAVAILABILITY STUDY DESIGNED TO EVALUATE THE PHARMACOKINETIC PROFILE OF VELUSETRAG FOLLOWING SINGLE-DOSE ADMINISTRATION OF INTRAVENOUS AND ORAL CAPSULE FORMULATIONS IN HEALTHY MALE AND FEMALE SUBJECTS

    Alfasigma

    chronic intestinal pseudo-obstruction (CIPO)

    phase 1 other active

    1 trial

  7. GLPG0634, Jyseleca 200 mg film-coated tablets, Jyseleca 100 mg film-coated tablets

    Alfasigma

    juvenile idiopathic arthritis

    phase 1 small molecule active

    1 trial

Frequently asked questions

What is Alfasigma?

Alfasigma (EDE7C49) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 7 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Alfasigma sponsor?

We track 7 ClinicalTrials.gov-linked programs for Alfasigma, including GLPG0634, Jyseleca 200 mg film-coated tablets, Jyseleca 100 mg film-coated tablets and 6 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Alfasigma company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.